Receptor Information
General Information of This Receptor
| Receptor ID |
REC00001
|
|||||
|---|---|---|---|---|---|---|
| Receptor Name |
Neuropilin-1 (NRP1)
|
|||||
| Gene Name |
NRP1
|
|||||
| Gene ID | ||||||
| Synonym |
NRP; VEGF165R; Vascular endothelial cell growth factor 165 receptor; CD_antigen=CD304
|
|||||
| Sequence |
MERGLPLLCAVLALVLAPAGAFRNDKCGDTIKIESPGYLTSPGYPHSYHPSEKCEWLIQA
PDPYQRIMINFNPHFDLEDRDCKYDYVEVFDGENENGHFRGKFCGKIAPPPVVSSGPFLF IKFVSDYETHGAGFSIRYEIFKRGPECSQNYTTPSGVIKSPGFPEKYPNSLECTYIVFVP KMSEIILEFESFDLEPDSNPPGGMFCRYDRLEIWDGFPDVGPHIGRYCGQKTPGRIRSSS GILSMVFYTDSAIAKEGFSANYSVLQSSVSEDFKCMEALGMESGEIHSDQITASSQYSTN WSAERSRLNYPENGWTPGEDSYREWIQVDLGLLRFVTAVGTQGAISKETKKKYYVKTYKI DVSSNGEDWITIKEGNKPVLFQGNTNPTDVVVAVFPKPLITRFVRIKPATWETGISMRFE VYGCKITDYPCSGMLGMVSGLISDSQITSSNQGDRNWMPENIRLVTSRSGWALPPAPHSY INEWLQIDLGEEKIVRGIIIQGGKHRENKVFMRKFKIGYSNNGSDWKMIMDDSKRKAKSF EGNNNYDTPELRTFPALSTRFIRIYPERATHGGLGLRMELLGCEVEAPTAGPTTPNGNLV DECDDDQANCHSGTGDDFQLTGGTTVLATEKPTVIDSTIQSEFPTYGFNCEFGWGSHKTF CHWEHDNHVQLKWSVLTSKTGPIQDHTGDGNFIYSQADENQKGKVARLVSPVVYSQNSAH CMTFWYHMSGSHVGTLRVKLRYQKPEEYDQLVWMAIGHQGDHWKEGRVLLHKSLKLYQVI FEGEIGKGNLGGIAVDDISINNHISQEDCAKPADLDKKNPEIKIDETGSTPGYEGEGEGD KNISRKPGNVLKTLDPILITIIAMSALGVLLGAVCGVVLYCACWHNGMSERNLSALENYN FELVDGVKLKKDKLNTQSTYSEA
Click to Show/Hide
|
|||||
| 3D Structure | ||||||
| Family |
the neuropilin family
|
|||||
| Function |
Cell-surface receptor involved in the development of the cardiovascular system, in angiogenesis, in the formation of certain neuronal circuits and in organogenesis outside the nervous system. Mediates the chemorepulsant activity of semaphorins . Recognizes a C-end rule (CendR) motif R/KXXR/K on its ligands which causes cellular internalization and vascular leakage . It binds to semaphorin 3A, the PLGF-2 isoform of PGF, the VEGF165 isoform of VEGFA and VEGFB . Coexpression with KDR results in increased VEGF165 binding to KDR as well as increased chemotaxis. Regulates VEGF-induced angiogenesis. Binding to VEGFA initiates a signaling pathway needed for motor neuron axon guidance and cell body migration, including for the caudal migration of facial motor neurons from rhombomere 4 to rhombomere 6 during embryonic development (By similarity). Regulates mitochondrial iron transport via interaction with ABCB8/MITOSUR . 97333,. (Microbial infection) Acts as a host factor for human coronavirus SARS-CoV-2 infection. Recognizes and binds to CendR motif RRAR on SARS-CoV-2 spike protein S1 which enhances SARS-CoV-2 infection. [Isoform 2]: Binds VEGF-165 and may inhibit its binding to cells . May induce apoptosis by sequestering VEGF-165 . May bind as well various members of the semaphorin family. Its expression has an averse effect on blood vessel number and integrity.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Peptide-drug Conjuate AND It's Component Related to This Receptor
Full List of The PDC Related to This Receptor
CDRGDK
| PDC Info | PDC Name | Drug | Target | Linker |
|---|---|---|---|---|
|
SN38(10)-4-CDRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
4-(2Disulfaneylethoxy)-4-oxobutanoic acid
|
|
|
SN38(10)-4-(Ac)CDRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
4-(2Disulfaneylethoxy)-4-oxobutanoic acid
|
|
|
SN38(10)-(Ac)CDRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
3-Disulfaneylpropanoic acid
|
CGVQIRGDK
| PDC Info | PDC Name | Drug | Target | Linker |
|---|---|---|---|---|
|
SN38(10)-(Ac)CGVQIRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
3-Disulfaneylpropanoic acid
|
|
|
SN38(10)-4-(Ac)CGVQIRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
4-(2Disulfaneylethoxy)-4-oxobutanoic acid
|
|
|
(MOM)SN38(20)-(Ac)CGVQIRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
3-Disulfaneylpropanoic acid
|
Chlorotoxin
| PDC Info | PDC Name | Drug | Target | Linker |
|---|---|---|---|---|
|
ER-472
|
Cryptophycin analog
|
Microtubule (MT)
|
Dimethyl disulfide
|
CRGDK
| PDC Info | PDC Name | Drug | Target | Linker |
|---|---|---|---|---|
|
SN38(10)-CRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
3-Disulfaneylpropanoic acid
|
|
|
SN38(10)-4-CRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
4-(2Disulfaneylethoxy)-4-oxobutanoic acid
|
|
|
SN38(10)-5-CRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
5-(2-Disulfaneylethoxy)-5-oxopentanoic acid
|
|
|
SN38(10)-(Ac)CRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
3-Disulfaneylpropanoic acid
|
|
|
SN38(10)-4-(Ac)CRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
4-(2Disulfaneylethoxy)-4-oxobutanoic acid
|
|
|
SN38(10)-5-(Ac)CRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
5-(2-Disulfaneylethoxy)-5-oxopentanoic acid
|
|
|
SN38(20)-4-CRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
4-(2Disulfaneylethoxy)-4-oxobutanoic acid
|
|
|
SN38(20)-CRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
3-Disulfaneylpropanoic acid
|
|
|
(MOM)SN38(20)-CRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
3-Disulfaneylpropanoic acid
|
|
|
(MOM)SN38(20)-(Ac)CRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
3-Disulfaneylpropanoic acid
|
CRRGDK
| PDC Info | PDC Name | Drug | Target | Linker |
|---|---|---|---|---|
|
SN38(10)-CRRGDK
|
7-Ethyl-10-hydroxycamptothecin
|
DNA topoisomerase 1 (TOP1)
|
3-Disulfaneylpropanoic acid
|
TAR
| PDC Info | PDC Name | Drug | Target | Linker |
|---|---|---|---|---|
|
PTX-SM-TAR
|
Paclitaxel
|
Microtubule (MT)
|
SA-MAL
|
